Thomas Tu

2.6k total citations · 1 hit paper
61 papers, 1.6k citations indexed

About

Thomas Tu is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Thomas Tu has authored 61 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Epidemiology, 50 papers in Hepatology and 8 papers in Infectious Diseases. Recurrent topics in Thomas Tu's work include Hepatitis B Virus Studies (51 papers), Hepatitis C virus research (42 papers) and Liver Disease Diagnosis and Treatment (30 papers). Thomas Tu is often cited by papers focused on Hepatitis B Virus Studies (51 papers), Hepatitis C virus research (42 papers) and Liver Disease Diagnosis and Treatment (30 papers). Thomas Tu collaborates with scholars based in Australia, Germany and United States. Thomas Tu's co-authors include Stephan Urban, Nicholas Shackel, Magdalena A. Budzinska, Ralf Bartenschlager, Sandra Bühler, Florian W. R. Vondran, Geoffrey W. McCaughan, Allison R. Jilbert, Stephen Locarnini and Susan V. McLennan and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Thomas Tu

57 papers receiving 1.6k citations

Hit Papers

HBV DNA Integration: Molecular Mechanisms and Clinical Im... 2017 2026 2020 2023 2017 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Tu Australia 21 1.3k 1.1k 271 148 148 61 1.6k
G. Raffa Italy 17 1.8k 1.4× 1.5k 1.3× 375 1.4× 186 1.3× 111 0.8× 30 2.0k
Chen Pan China 11 1.6k 1.2× 1.2k 1.1× 353 1.3× 314 2.1× 202 1.4× 32 2.0k
Florian A. Lempp Germany 20 1.8k 1.3× 1.4k 1.3× 271 1.0× 308 2.1× 178 1.2× 30 2.0k
Danny Wong Hong Kong 22 1.3k 1.0× 1.2k 1.1× 231 0.9× 115 0.8× 114 0.8× 41 1.7k
Hussein Hassan Aly Japan 16 541 0.4× 503 0.4× 310 1.1× 128 0.9× 149 1.0× 37 995
Alexander S. Kekulé Germany 13 767 0.6× 427 0.4× 334 1.2× 165 1.1× 104 0.7× 27 1.1k
Dongping Xu China 22 1.4k 1.1× 1.2k 1.1× 152 0.6× 219 1.5× 382 2.6× 66 1.7k
Runu Chakravarty India 24 1.0k 0.8× 902 0.8× 253 0.9× 119 0.8× 65 0.4× 63 1.4k
Christophe Ramière France 18 478 0.4× 518 0.5× 200 0.7× 305 2.1× 108 0.7× 33 1.0k

Countries citing papers authored by Thomas Tu

Since Specialization
Citations

This map shows the geographic impact of Thomas Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Tu more than expected).

Fields of papers citing papers by Thomas Tu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Tu. The network helps show where Thomas Tu may publish in the future.

Co-authorship network of co-authors of Thomas Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Tu. A scholar is included among the top collaborators of Thomas Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Tu. Thomas Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beatty, Julia A., Thomas Tu, & John M. Cullen. (2025). Domestic Cat Hepadnavirus, a Hepatitis B-like Virus Associated with Feline Liver Disease. Veterinary Clinics of North America Small Animal Practice. 55(4). 615–626. 1 indexed citations
2.
Teng, Chiao‐Fang, Hung‐Wen Tsai, Yuanyuan Liu, et al.. (2025). Novel digital droplet inverse PCR assay shows that natural clearance of hepatitis B infection is associated with fewer viral integrations. Emerging Microbes & Infections. 14(1). 2450025–2450025. 1 indexed citations
3.
Tu, Thomas, Thomas McQuaid, & Ira M. Jacobson. (2024). HBV‐Induced Carcinogenesis: Mechanisms, Correlation With Viral Suppression, and Implications for Treatment. Liver International. 45(1). e16202–e16202. 5 indexed citations
4.
Khan, Anis A., Enoch Tay, Eve Diefenbach, et al.. (2024). Hepatitis B Virus and Hepatitis C Virus Affect Mitochondrial Function Through Different Metabolic Pathways, Explaining Virus-Specific Clinical Features of Chronic Hepatitis. The Journal of Infectious Diseases. 230(5). e1012–e1022. 10 indexed citations
5.
Freeland, Catherine, et al.. (2024). Quality of life of people living with chronic hepatitis B: The role of social support system. SHILAP Revista de lepidopterología. 4(4). e0003103–e0003103. 1 indexed citations
6.
Freeland, Catherine, Jack Wallace, Hailemichael Desalegn, et al.. (2024). Hepatitis B discrimination: global responses requiring global data. BMC Public Health. 24(1). 1575–1575. 5 indexed citations
7.
Freeland, Catherine, et al.. (2024). The urgent need to end hepatitis B stigma and discrimination. ˜The œLancet. Gastroenterology & hepatology. 10(2). 105–107. 2 indexed citations
8.
Nekouei, Omid, et al.. (2023). Domestic Cat Hepadnavirus and Pathogenic Retroviruses; A Sero-Molecular Survey of Cats in Santiago, Chile. Viruses. 16(1). 46–46. 3 indexed citations
9.
Tu, Thomas, et al.. (2023). Novel Assays to Solve the Clinical and Scientific Challenges of Chronic Hepatitis B. Clinics in Liver Disease. 27(4). 837–855. 1 indexed citations
10.
Howell, Jessica, Jack Wallace, Yinzong Xiao, et al.. (2023). Pathway to global elimination of hepatitis B: HBV cure is just the first step. Hepatology. 78(3). 976–990. 20 indexed citations
11.
Capozza, Paolo, Maura Carrai, Thomas Tu, et al.. (2023). Domestic Cat Hepadnavirus: Molecular Epidemiology and Phylogeny in Cats in Hong Kong. Viruses. 15(1). 150–150. 16 indexed citations
12.
Tu, Thomas, et al.. (2023). Targeting Hepatitis B Virus DNA Using Designer Gene Editors. Clinics in Liver Disease. 27(4). 895–916. 6 indexed citations
13.
Tu, Thomas. (2022). Stigma: a major barrier to hepatitis B elimination. Nature Reviews Gastroenterology & Hepatology. 19(10). 622–622. 7 indexed citations
15.
Budzinska, Magdalena A., James G. Kench, Michael Stapelberg, et al.. (2019). Virus Genotype-Dependent Transcriptional Alterations in Lipid Metabolism and Inflammation Pathways in the Hepatitis C Virus-infected Liver. Scientific Reports. 9(1). 10596–10596. 19 indexed citations
16.
Mutz, Pascal, Philippe Metz, Florian A. Lempp, et al.. (2018). HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon. Gastroenterology. 154(6). 1791–1804.e22. 126 indexed citations
17.
Tu, Thomas & Stephan Urban. (2018). Detection of Low Copy Number Integrated Viral DNA Formed by <em>In Vitro</em> Hepatitis B Infection. Journal of Visualized Experiments. 2 indexed citations
18.
Tu, Thomas & Allison R. Jilbert. (2016). Detection of Hepatocyte Clones Containing Integrated Hepatitis B Virus DNA Using Inverse Nested PCR. Methods in molecular biology. 1540. 97–118. 21 indexed citations
19.
Budzinska, Magdalena A., et al.. (2016). Accumulation of Deleterious Passenger Mutations Is Associated with the Progression of Hepatocellular Carcinoma. PLoS ONE. 11(9). e0162586–e0162586. 12 indexed citations
20.
Cheng, Robert Y.S., Thomas Tu, Nicholas Shackel, & Geoffrey W. McCaughan. (2014). Advances in and the future of treatments for hepatitis C. Expert Review of Gastroenterology & Hepatology. 8(6). 633–647. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026